Terms: = Kidney tumors AND RUNX1, PEBP2A2, 861, ENSG00000159216, Q01196, AML1, CBFA2, AMLCR1 AND Prognosis
14 results:
1. Identification of prognostic stemness-related genes in kidney renal papillary cell carcinoma.
Liu Y; Yao Y; Zhang Y; Xu C; Yang T; Qu M; Lu B; Song X; Pan X; Zhou W; Cui X
BMC Med Genomics; 2024 May; 17(1):121. PubMed ID: 38702698
[TBL] [Abstract] [Full Text] [Related]
2. Integrative epigenome-transcriptome analysis unravels cancer-specific over-expressed genes potentially regulating immune microenvironment in clear cell renal cell carcinoma.
Gadewal N; Natu A; Sen S; Rauniyar S; Bastikar V; Gupta S
Biochim Biophys Acta Gen Subj; 2024 May; 1868(5):130596. PubMed ID: 38471632
[TBL] [Abstract] [Full Text] [Related]
3. runx1 predicts poor prognosis and correlates with tumor progression in clear cell renal carcinoma.
Ma J; He S; Li M; Peng Y; Yang X; Chen L; Jia Q; Liu Y
Pathol Res Pract; 2023 Nov; 251():154886. PubMed ID: 37844486
[TBL] [Abstract] [Full Text] [Related]
4. Clinicopathological characteristics and outcomes of synchronous renal cell carcinoma and urothelial carcinoma: A population-based analysis.
Wu K; Liu X; Wang Y; Wang X; Li X
Front Public Health; 2022; 10():994351. PubMed ID: 36388369
[TBL] [Abstract] [Full Text] [Related]
5. Albumin levels predict prognosis in advanced renal cell carcinoma treated with tyrosine kinase inhibitors: a systematic review and meta-analysis.
Zhou X; Fu G; Zu X; Xu Z; Li HT; D'souza A; Tulpule V; Quinn DI; Bhowmick NA; Weisenberger DJ; Liang G; Chen J
Urol Oncol; 2022 Jan; 40(1):12.e13-12.e22. PubMed ID: 34454823
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic relevance of ABO blood group system in non-metastatic renal cell carcinoma: An analysis of two independent European cohorts with long-term follow-up.
Barth DA; Sareban N; Lindner AK; Daller LAJ; Matzhold EM; Hutterer G; Smolle M; Mischinger J; Riedl JM; Seles M; Mannweiler S; Bauernhofer T; Pummer K; Pichler R; Zigeuner R; Schlenke P; Pichler M
Urol Oncol; 2021 Oct; 39(10):736.e9-736.e16. PubMed ID: 34247906
[TBL] [Abstract] [Full Text] [Related]
7. Association of Acute kidney Injury Receiving kidney Replacement Therapy With prognosis of Critically Ill Patients With and Without Cancer: A Retrospective Study.
Druml W; Zajic P; Schellongowski P; Fellinger T; Metnitz B; Posch M; Metnitz PGH
Crit Care Med; 2021 Nov; 49(11):1932-1942. PubMed ID: 34166290
[TBL] [Abstract] [Full Text] [Related]
8. Genetic profile and immunohistochemical study of clear cell renal carcinoma: Pathological-anatomical correlation and prognosis.
Diez-Calzadilla NA; Noguera Salvá R; Soriano Sarrió P; Martínez-Jabaloyas JM
Cancer Treat Res Commun; 2021; 27():100374. PubMed ID: 33932757
[TBL] [Abstract] [Full Text] [Related]
9. A Gene Signature of Survival Prediction for kidney Renal Cell Carcinoma by Multi-Omic Data Analysis.
Hu F; Zeng W; Liu X
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31739630
[TBL] [Abstract] [Full Text] [Related]
10. A large-scale transcriptome analysis identified ELANE and PRTN3 as novel methylation prognostic signatures for clear cell renal cell carcinoma.
Wei Z; Wu B; Wang L; Zhang J
J Cell Physiol; 2020 Mar; 235(3):2582-2589. PubMed ID: 31490025
[TBL] [Abstract] [Full Text] [Related]
11. Overexpression of low density lipoprotein receptor-related protein 1 (LRP1) is associated with worsened prognosis and decreased cancer immunity in clear-cell renal cell carcinoma.
Feng C; Ding G; Ding Q; Wen H
Biochem Biophys Res Commun; 2018 Sep; 503(3):1537-1543. PubMed ID: 30033103
[TBL] [Abstract] [Full Text] [Related]
12. Survival of macrovascular disease, chronic kidney disease, chronic respiratory disease, cancer and smoking in patients with type 2 diabetes: BioBank Japan cohort.
Yokomichi H; Nagai A; Hirata M; Kiyohara Y; Muto K; Ninomiya T; Matsuda K; Kamatani Y; Tamakoshi A; Kubo M; Nakamura Y; ; Yamagata Z
J Epidemiol; 2017 Mar; 27(3S):S98-S106. PubMed ID: 28209242
[TBL] [Abstract] [Full Text] [Related]
13. Nuclear expression of Lyn, a Src family kinase member, is associated with poor prognosis in renal cancer patients.
Roseweir AK; Qayyum T; Lim Z; Hammond R; MacDonald AI; Fraser S; Oades GM; Aitchison M; Jones RJ; Edwards J
BMC Cancer; 2016 Mar; 16():229. PubMed ID: 26984511
[TBL] [Abstract] [Full Text] [Related]
14. [WT 1 and leukemia].
Inoue K; Sugiyama H
Rinsho Ketsueki; 1995 Jun; 36(6):552-8. PubMed ID: 7643450
[TBL] [Abstract] [Full Text] [Related]
